{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:20:26Z","timestamp":1774084826527,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hangzhou Zijingang Science & Technology City High-level Talent Plan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-024-00705-6","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T22:31:56Z","timestamp":1738881116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers"],"prefix":"10.1186","volume":"19","author":[{"given":"Hua","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibo","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runzhi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"2","key":"705_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/biomedicines9020103","volume":"9","author":"N Tifoun","year":"2021","unstructured":"Tifoun N, De Las Heras JM, Guillaume A, Bouleau S, Mignotte B, Le Floch N. Insights into the roles of the sideroflexins\/SLC56 family in iron homeostasis and iron-sulfur biogenesis. Biomedicines. 2021;9(2):103.","journal-title":"Biomedicines"},{"key":"705_CR2","doi-asserted-by":"publisher","first-page":"708754","DOI":"10.3389\/fcell.2021.708754","volume":"9","author":"MM Attwood","year":"2021","unstructured":"Attwood MM, Schioth HB. Characterization of five transmembrane proteins: with focus on the tweety, sideroflexin, and YIP1 domain families. Front Cell Dev Biol. 2021;9:708754.","journal-title":"Front Cell Dev Biol"},{"key":"705_CR3","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1126\/science.aat9528","volume":"362","author":"N Kory","year":"2018","unstructured":"Kory N, Wyant GA, Prakash G, Uit de Bos J, Bottanelli F, Pacold ME, Chan SH, Lewis CA, Wang T, Keys HR, et al. SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism. Science. 2018;362:6416.","journal-title":"Science"},{"issue":"1","key":"705_CR4","doi-asserted-by":"publisher","first-page":"19634","DOI":"10.1038\/s41598-019-55907-z","volume":"9","author":"BT Paul","year":"2019","unstructured":"Paul BT, Tesfay L, Winkler CR, Torti FM, Torti SV. Sideroflexin 4 affects Fe-S cluster biogenesis, iron metabolism, mitochondrial respiration and heme biosynthetic enzymes. Sci Rep. 2019;9(1):19634.","journal-title":"Sci Rep"},{"issue":"13","key":"705_CR5","doi-asserted-by":"publisher","first-page":"e2115566119","DOI":"10.1073\/pnas.2115566119","volume":"119","author":"TD Jackson","year":"2022","unstructured":"Jackson TD, Crameri JJ, Muellner-Wong L, Frazier AE, Palmer CS, Formosa LE, Hock DH, Fujihara KM, Stait T, Sharpe AJ, et al. Sideroflexin 4 is a complex I assembly factor that interacts with the MCIA complex and is required for the assembly of the ND2 module. Proc Natl Acad Sci USA. 2022;119(13):e2115566119.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"705_CR6","doi-asserted-by":"publisher","first-page":"19936","DOI":"10.1038\/s41598-022-24391-3","volume":"12","author":"L Tesfay","year":"2022","unstructured":"Tesfay L, Paul BT, Hegde P, Brewer M, Habbani S, Jellison E, Moore T, Wu H, Torti SV, Torti FM. Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer. Sci Rep. 2022;12(1):19936.","journal-title":"Sci Rep"},{"issue":"3","key":"705_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4049\/jimmunol.2200863","volume":"211","author":"H Zhang","year":"2023","unstructured":"Zhang H, Meng L, Liu Y, Jiang J, He Z, Qin J, Wang C, Yang M, He K, Yang J, et al. Sfxn5 regulation of actin polymerization for neutrophil spreading depends on a citrate-cholesterol-PI(4,5)P2 pathway. J Immunol. 2023;211(3):462\u201373.","journal-title":"J Immunol"},{"issue":"16","key":"705_CR8","doi-asserted-by":"publisher","first-page":"12797","DOI":"10.3390\/ijms241612797","volume":"24","author":"G Rafikova","year":"2023","unstructured":"Rafikova G, Gilyazova I, Enikeeva K, Pavlov V, Kzhyshkowska J. Prostate cancer: genetics, epigenetics and the need for immunological biomarkers. Int J Mol Sci. 2023;24(16):12797.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"705_CR9","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.3390\/ijms24032185","volume":"24","author":"BE Boehm","year":"2023","unstructured":"Boehm BE, York ME, Petrovics G, Kohaar I, Chesnut GT. Biomarkers of aggressive prostate cancer at diagnosis. Int J Mol Sci. 2023;24(3):2185.","journal-title":"Int J Mol Sci"},{"issue":"S3","key":"705_CR10","first-page":"24","volume":"27","author":"A Uhr","year":"2020","unstructured":"Uhr A, Glick L, Gomella LG. An overview of biomarkers in the diagnosis and management of prostate cancer. Can J Urol. 2020;27(S3):24\u20137.","journal-title":"Can J Urol"},{"issue":"8","key":"705_CR11","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3390\/ijms20081813","volume":"20","author":"I Kohaar","year":"2019","unstructured":"Kohaar I, Petrovics G, Srivastava S. A rich array of prostate cancer molecular biomarkers: opportunities and challenges. Int J Mol Sci. 2019;20(8):1813.","journal-title":"Int J Mol Sci"},{"key":"705_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2164-7-92","volume":"7","author":"AJ Oudes","year":"2006","unstructured":"Oudes AJ, Campbell DS, Sorensen CM, Walashek LS, True LD, Liu AY. Transcriptomes of human prostate cells. BMC Genom. 2006;7:92.","journal-title":"BMC Genom"},{"issue":"7757","key":"705_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jane-Valbuena J, Kryukov GV, Lo CC, McDonald ER 3rd, Barretina J, Gelfand ET, Bielski CM, Li H, et al. Next-generation characterization of the cancer cell line encyclopedia. Nature. 2019;569(7757):503\u20138.","journal-title":"Nature"},{"issue":"6","key":"705_CR14","first-page":"530","volume":"11","author":"H Xu","year":"2023","unstructured":"Xu H, Liu W, He C, Mirza M, Li B. Aberrant expression of multiple glycolytic enzyme genes is significantly associated with disease progression and survival outcomes in prostate cancers. Am J Clin Exp Urol. 2023;11(6):530\u201341.","journal-title":"Am J Clin Exp Urol"},{"issue":"6","key":"705_CR15","first-page":"578","volume":"11","author":"H Huang","year":"2023","unstructured":"Huang H, Song S, Liu W, Ye S, Bao Y, Mirza M, Li B, Huang J, Zhu R, Lian H. Expressions of glucose transporter genes are diversely attenuated and significantly associated with prostate cancer progression. Am J Clin Exp Urol. 2023;11(6):578\u201393.","journal-title":"Am J Clin Exp Urol"},{"key":"705_CR16","doi-asserted-by":"publisher","first-page":"1087082","DOI":"10.3389\/fonc.2023.1087082","volume":"13","author":"C He","year":"2023","unstructured":"He C, Liu W, Sun J, Zhang D, Li B. Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers. Front Oncol. 2023;13:1087082.","journal-title":"Front Oncol"},{"key":"705_CR17","doi-asserted-by":"publisher","first-page":"1023455","DOI":"10.3389\/fonc.2022.1023455","volume":"12","author":"J Huang","year":"2022","unstructured":"Huang J, Liu W, Zhang D, Lin B, Li B. TMEM158 expression is negatively regulated by AR signaling and associated with favorite survival outcomes in prostate cancers. Front Oncol. 2022;12:1023455.","journal-title":"Front Oncol"},{"issue":"2","key":"705_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4103\/aja202240","volume":"25","author":"J Huang","year":"2023","unstructured":"Huang J, Liu W, Lin BY, Li JC, Lu J, Li BY. Scaffold protein MAPK8IP2 expression is a robust prognostic factor in prostate cancer associated with AR signaling activity. Asian J Androl. 2023;25(2):198\u2013207.","journal-title":"Asian J Androl"},{"key":"705_CR19","doi-asserted-by":"publisher","first-page":"827344","DOI":"10.3389\/fonc.2021.827344","volume":"11","author":"C Tao","year":"2021","unstructured":"Tao C, Liu W, Yan X, Yang M, Yao S, Shu Q, Li B, Zhu R. PAQR5 expression is suppressed by TGFbeta1 and associated with a poor survival outcome in renal clear cell carcinoma. Front Oncol. 2021;11:827344.","journal-title":"Front Oncol"},{"issue":"9","key":"705_CR20","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/biom11091383","volume":"11","author":"M Yang","year":"2021","unstructured":"Yang M, Li JC, Tao C, Wu S, Liu B, Shu Q, Li B, Zhu R. PAQR6 upregulation is associated with AR signaling and unfavorite prognosis in prostate cancers. Biomolecules. 2021;11(9):1383.","journal-title":"Biomolecules"},{"key":"705_CR21","doi-asserted-by":"publisher","first-page":"1080055","DOI":"10.3389\/fphar.2022.1080055","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang J, Liu W, Song S, Li JC, Gan K, Shen C, Holzbeierlein J, Li B. The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma. Front Pharmacol. 2022;13:1080055.","journal-title":"Front Pharmacol"},{"key":"705_CR22","doi-asserted-by":"publisher","first-page":"714756","DOI":"10.3389\/fonc.2021.714756","volume":"11","author":"J Wang","year":"2021","unstructured":"Wang J, Liu W, Li JC, Li M, Li B, Zhu R. Hepcidin downregulation correlates with disease aggressiveness and immune infiltration in liver cancers. Front Oncol. 2021;11:714756.","journal-title":"Front Oncol"},{"issue":"12","key":"705_CR23","doi-asserted-by":"publisher","first-page":"181006","DOI":"10.1098\/rsos.181006","volume":"5","author":"O Menyhart","year":"2018","unstructured":"Menyhart O, Nagy A, Gyorffy B. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci. 2018;5(12):181006.","journal-title":"R Soc Open Sci"},{"issue":"23","key":"705_CR24","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, Cieslik M, Benelli M, Robinson D, Van Allen EM, et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci USA. 2019;116(23):11428\u201336.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"705_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41698-024-00667-x","volume":"8","author":"S Cheng","year":"2024","unstructured":"Cheng S, Li L, Yeh Y, Shi Y, Franco O, Corey E, Yu X. Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis. NPJ Precis Oncol. 2024;8(1):171.","journal-title":"NPJ Precis Oncol"},{"issue":"3","key":"705_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1432-0436.2006.00135.x","volume":"75","author":"XD Wang","year":"2007","unstructured":"Wang XD, Wang BE, Soriano R, Zha J, Zhang Z, Modrusan Z, Cunha GR, Gao WQ. Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis. Differentiation. 2007;75(3):219\u201334.","journal-title":"Differentiation"},{"issue":"2","key":"705_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1158\/0008-5472.CAN-11-3004","volume":"72","author":"Y Sun","year":"2012","unstructured":"Sun Y, Wang BE, Leong KG, Yue P, Li L, Jhunjhunwala S, Chen D, Seo K, Modrusan Z, Gao WQ, et al. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy. Cancer Res. 2012;72(2):527\u201336.","journal-title":"Cancer Res"},{"issue":"4","key":"705_CR28","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1158\/0008-5472.CAN-09-2984","volume":"70","author":"N Terada","year":"2010","unstructured":"Terada N, Shimizu Y, Kamba T, Inoue T, Maeno A, Kobayashi T, Nakamura E, Kamoto T, Kanaji T, Maruyama T, et al. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. Cancer Res. 2010;70(4):1606\u201315.","journal-title":"Cancer Res"},{"issue":"1","key":"705_CR29","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41467-021-21898-7","volume":"12","author":"C Pacini","year":"2021","unstructured":"Pacini C, Dempster JM, Boyle I, Goncalves E, Najgebauer H, Karakoc E, van der Meer D, Barthorpe A, Lightfoot H, Jaaks P, et al. Integrated cross-study datasets of genetic dependencies in cancer. Nat Commun. 2021;12(1):1661.","journal-title":"Nat Commun"},{"issue":"1","key":"705_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13059-021-02540-7","volume":"22","author":"JM Dempster","year":"2021","unstructured":"Dempster JM, Boyle I, Vazquez F, Root DE, Boehm JS, Hahn WC, Tsherniak A, McFarland JM. Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects. Genome Biol. 2021;22(1):343.","journal-title":"Genome Biol"},{"key":"705_CR31","doi-asserted-by":"publisher","first-page":"1397116","DOI":"10.3389\/fphar.2024.1397116","volume":"15","author":"W Liu","year":"2024","unstructured":"Liu W, He C, Li C, Ye S, Zhao J, Zhu C, Wang X, Ma Q, Li B. Natural compound alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death. Front Pharmacol. 2024;15:1397116.","journal-title":"Front Pharmacol"},{"issue":"6","key":"705_CR32","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1158\/1535-7163.MCT-13-0981","volume":"13","author":"Y Tang","year":"2014","unstructured":"Tang Y, Chen R, Huang Y, Li G, Huang Y, Chen J, Duan L, Zhu BT, Thrasher JB, Zhang X, et al. Natural compound alternol induces oxidative stress-dependent apoptotic cell death preferentially in prostate cancer cells. Mol Cancer Ther. 2014;13(6):1526\u201336.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"705_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1158\/1535-7163.MCT-04-0313","volume":"4","author":"X Liao","year":"2005","unstructured":"Liao X, Tang S, Thrasher JB, Griebling TL, Li B. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol Cancer Ther. 2005;4(4):505\u201315.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"705_CR34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41419-022-05272-z","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Qian J, Ding P, Wang W, Li X, Tang X, Tang C, Yang Y, Gu C. Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation. Cell Death Dis. 2022;13(9):822.","journal-title":"Cell Death Dis"},{"issue":"2","key":"705_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12576-018-0652-2","volume":"69","author":"EE Mon","year":"2019","unstructured":"Mon EE, Wei FY, Ahmad RNR, Yamamoto T, Moroishi T, Tomizawa K. Regulation of mitochondrial iron homeostasis by sideroflexin 2. J Physiol Sci. 2019;69(2):359\u201373.","journal-title":"J Physiol Sci"},{"issue":"4","key":"705_CR36","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"Cancer Genome Atlas Research N","year":"2015","unstructured":"Cancer Genome Atlas Research N. The molecular taxonomy of primary prostate cancer. Cell. 2015;163(4):1011\u201325.","journal-title":"Cell"},{"key":"705_CR37","doi-asserted-by":"publisher","first-page":"101158","DOI":"10.1016\/j.drup.2024.101158","volume":"77","author":"D Gao","year":"2024","unstructured":"Gao D, Shen Y, Xu L, Sun Y, Hu H, Xu B, Wang Z, Xu H. Acetate utilization promotes hormone therapy resistance in prostate cancer through neuroendocrine differentiation. Drug Resist Updat. 2024;77:101158.","journal-title":"Drug Resist Updat"},{"issue":"4","key":"705_CR38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.annonc.2020.02.002","volume":"31","author":"R Ge","year":"2020","unstructured":"Ge R, Wang Z, Montironi R, Jiang Z, Cheng M, Santoni M, Huang K, Massari F, Lu X, Cimadamore A, et al. Epigenetic modulations and lineage plasticity in advanced prostate cancer. Ann Oncol. 2020;31(4):470\u20139.","journal-title":"Ann Oncol"},{"issue":"1","key":"705_CR39","doi-asserted-by":"publisher","first-page":"20230685","DOI":"10.1515\/med-2023-0685","volume":"18","author":"D Yuan","year":"2023","unstructured":"Yuan D, Liu J, Sang W, Li Q. Comprehensive analysis of the role of SFXN family in breast cancer. Open Med (Wars). 2023;18(1):20230685.","journal-title":"Open Med (Wars)"},{"issue":"10","key":"705_CR40","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.7150\/ijms.86990","volume":"20","author":"Z Du","year":"2023","unstructured":"Du Z, Zhang Z, Han X, Xie H, Yan W, Tian D, Liu M, Rao C. Comprehensive analysis of sideroflexin 4 in hepatocellular carcinoma by bioinformatics and experiments. Int J Med Sci. 2023;20(10):1300\u201315.","journal-title":"Int J Med Sci"},{"issue":"5","key":"705_CR41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2174\/1566523223666230724121515","volume":"23","author":"Y Dong","year":"2023","unstructured":"Dong Y, Jin F, Wang J, Li Q, Huang Z, Xia L, Yang M. SFXN3 is associated with poor clinical outcomes and sensitivity to the hypomethylating therapy in non-M3 acute myeloid leukemia patients. Curr Gene Ther. 2023;23(5):410\u20138.","journal-title":"Curr Gene Ther"},{"issue":"3","key":"705_CR42","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s12013-024-01326-5","volume":"82","author":"F Jin","year":"2024","unstructured":"Jin F, He L, Wang J, Zhang Y, Yang M. SFXN3 is a prognostic marker and promotes the growth of acute myeloid leukemia. Cell Biochem Biophys. 2024;82(3):2195\u2013204.","journal-title":"Cell Biochem Biophys"},{"key":"705_CR43","doi-asserted-by":"publisher","first-page":"920136","DOI":"10.3389\/fimmu.2022.920136","volume":"13","author":"K Chen","year":"2022","unstructured":"Chen K, Gong S, Fang X, Li Q, Ye M, Li J, Huang S, Zhao Y, Liu N, Li Y, et al. Non-coding RNA-mediated high expression of SFXN3 as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancer. Front Immunol. 2022;13:920136.","journal-title":"Front Immunol"},{"key":"705_CR44","doi-asserted-by":"publisher","first-page":"e15592","DOI":"10.7717\/peerj.15592","volume":"11","author":"T Jin","year":"2023","unstructured":"Jin T, Ge L, Chen J, Wang W, Zhang L, Ge M. Identification of iron metabolism-related genes as prognostic indicators for papillary thyroid carcinoma: a retrospective study. PeerJ. 2023;11:e15592.","journal-title":"PeerJ"},{"key":"705_CR45","doi-asserted-by":"publisher","first-page":"1056648","DOI":"10.3389\/fnut.2022.1056648","volume":"9","author":"H Zhou","year":"2022","unstructured":"Zhou H, Wang F, Niu T. Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia. Front Nutr. 2022;9:1056648.","journal-title":"Front Nutr"},{"key":"705_CR46","doi-asserted-by":"publisher","first-page":"111918","DOI":"10.1016\/j.intimp.2024.111918","volume":"132","author":"Y Li","year":"2024","unstructured":"Li Y, Yang W, Liu C, Zhou S, Liu X, Zhang T, Wu L, Li X, Zhang J, Chang E. SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: a potential therapeutic target. Int Immunopharmacol. 2024;132:111918.","journal-title":"Int Immunopharmacol"},{"key":"705_CR47","doi-asserted-by":"publisher","first-page":"217008","DOI":"10.1016\/j.canlet.2024.217008","volume":"597","author":"L Andriani","year":"2024","unstructured":"Andriani L, Ling YX, Yang SY, Zhao Q, Ma XY, Huang MY, Zhang YL, Zhang FL, Li DQ, Shao ZM. Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A. Cancer Lett. 2024;597:217008.","journal-title":"Cancer Lett"},{"issue":"1","key":"705_CR48","doi-asserted-by":"publisher","first-page":"9449","DOI":"10.1038\/s41598-023-36660-w","volume":"13","author":"K Yagi","year":"2023","unstructured":"Yagi K, Shimada S, Akiyama Y, Hatano M, Asano D, Ishikawa Y, Ueda H, Watanabe S, Akahoshi K, Ono H, et al. Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma. Sci Rep. 2023;13(1):9449.","journal-title":"Sci Rep"},{"key":"705_CR49","doi-asserted-by":"publisher","first-page":"107449","DOI":"10.1016\/j.lungcan.2023.107449","volume":"188","author":"YH Zhang","year":"2024","unstructured":"Zhang YH, Liu XS, Gao Y, Yuan LL, Huang ZM, Zhang Y, Liu ZY, Yang Y, Liu XY, Ke CB, et al. SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with (18)F-FDG metabolic parameters. Lung Cancer. 2024;188:107449.","journal-title":"Lung Cancer"},{"issue":"1","key":"705_CR50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12885-023-11646-z","volume":"24","author":"W Liu","year":"2024","unstructured":"Liu W, Du Q, Mei T, Wang J, Huang D, Qin T. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma. BMC Cancer. 2024;24(1):94.","journal-title":"BMC Cancer"},{"key":"705_CR51","doi-asserted-by":"publisher","first-page":"154031","DOI":"10.1016\/j.prp.2022.154031","volume":"237","author":"L Chen","year":"2022","unstructured":"Chen L, Kang Y, Jiang Y, You J, Huang C, Xu X, Chen F. Overexpression of SFXN1 indicates poor prognosis and promotes tumor progression in lung adenocarcinoma. Pathol Res Pract. 2022;237:154031.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"705_CR52","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.21037\/tcr.2019.06.34","volume":"8","author":"Q Chen","year":"2019","unstructured":"Chen Q, Wang R, Zhang J, Zhou L. Sideroflexin1 as a novel tumor marker independently predicts survival in lung adenocarcinoma. Transl Cancer Res. 2019;8(4):1170\u20138.","journal-title":"Transl Cancer Res"},{"issue":"5","key":"705_CR53","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s10142-022-00883-3","volume":"22","author":"HH Dang","year":"2022","unstructured":"Dang HH, Ta HDK, Nguyen TTT, Anuraga G, Wang CY, Lee KH, Le NQK. Prospective role and immunotherapeutic targets of sideroflexin protein family in lung adenocarcinoma: evidence from bioinformatics validation. Funct Integr Genom. 2022;22(5):1057\u201372.","journal-title":"Funct Integr Genom"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-024-00705-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-024-00705-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-024-00705-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T23:26:00Z","timestamp":1738884360000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-024-00705-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["705"],"URL":"https:\/\/doi.org\/10.1186\/s40246-024-00705-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5442270\/v1","asserted-by":"object"}]},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declared no commercial or financial relationships construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}